scispace - formally typeset
J

Jonathan C. Silverstein

Researcher at University of Pittsburgh

Publications -  87
Citations -  1848

Jonathan C. Silverstein is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Visualization & Health care. The author has an hindex of 20, co-authored 82 publications receiving 1516 citations. Previous affiliations of Jonathan C. Silverstein include University of Illinois at Chicago & Northwestern University.

Papers
More filters
Journal ArticleDOI

The human body at cellular resolution: the NIH Human Biomolecular Atlas Program

Michael Snyder, +133 more
- 09 Oct 2019 - 
TL;DR: The NIH Common Fund Human Biomolecular Atlas Program (HuBMAP) intends to develop a widely accessible framework for comprehensively mapping the human body at single-cell resolution by supporting technology development, data acquisition, and detailed spatial mapping.
Journal Article

Prognostic factors associated with resectable adenocarcinoma of the head of the pancreas

TL;DR: Performing pancreaticoduodenectomy for adenocarcinoma of the head of the pancreas with negative microscopic margins of resection and without intraoperative transfusion significantly improves survival.
Journal ArticleDOI

A 15-Year Review of Esophagectomy for Carcinoma of the Esophagus and Cardia

TL;DR: In this paper, the authors evaluated the effect of surgical approach and adjuvant therapy on patients with carcinoma of the esophagus and/or cardia on patients who underwent esophagectomy.
Journal ArticleDOI

The science of Learning Health Systems: Foundations for a new journal.

TL;DR: This research presents a meta-anatomy of the human microbiome, a probabilistic model of the immune response to infectious disease, which helps doctors and researchers better understand the immune system and formulate treatment plans.
Journal ArticleDOI

Primary care physician PSA screening practices before and after the final U.S. Preventive Services Task Force recommendation.

TL;DR: There is evidence of continuing decreases in PSA testing by PCPs, which may be shifting toward more selective screening practices, as decreases in screening are most pronounced in the youngest and oldest patients and in those with history of PSA values<2.5 ng/ml.